RESUMEN
OBJECTIVE: The aim of this study was to quantitatively and qualitatively evaluate pulmonary 64-MDCT angiography image quality in pregnancy and puerperium, compared with female nonpregnant control subjects. MATERIALS AND METHODS: The study group comprised 124 consecutive pregnant and postpartum women and 124 female nonpregnant control subjects who presented with suspected pulmonary embolism. The individual studies were evaluated for subjective and objective diagnostic quality. RESULTS: Objective measurements of the arterial enhancement in the pulmonary trunk and left and right pulmonary arteries found that there was no statistically significant difference in attenuation values between the pregnant and puerperium group and the control group for pulmonary artery opacification. The mean attenuation in the pulmonary trunk was 270.54 HU in the pregnant group, 277.53 HU in the puerperium group, and 293.90 HU in the control group. CONCLUSION: We found no significant difference in diagnostic quality of pulmonary CT angiography using MDCT between the study and control groups. The use of MDCT acquisition, faster injection rates, higher contrast medium concentration, and higher trigger levels may decrease the number of nondiagnostic studies in this population. MDCT may be a worthwhile investigation in the majority of pregnant patients with suspected pulmonary embolism.
Asunto(s)
Angiografía/métodos , Embolia Pulmonar/diagnóstico por imagen , Tomografía Computarizada por Rayos X/métodos , Adolescente , Adulto , Estudios de Casos y Controles , Medios de Contraste , Diagnóstico Diferencial , Femenino , Humanos , Yohexol , Persona de Mediana Edad , Periodo Posparto , Embarazo , Estudios RetrospectivosRESUMEN
INTRODUCTION: Clinically unsuspected pulmonary embolism (PE) can be detected in oncology patients undergoing computed tomography (CT) imaging for reasons other than for PE diagnosis, but there is little prospective data on its true prevalence, clinical importance, or on methods to improve detection. METHODS: In consecutive oncology patients undergoing CT imaging of the chest for indications other than PE detection, CT pulmonary angiography (CTPA) was systematically included as part of the imaging protocol. Each imaging study was prospectively analyzed for the presence of PE. A 6-month follow-up was performed. Institutional review board approval was obtained. RESULTS: Four hundred seven oncology patients were included. Indications for chest CT imaging included baseline staging (31%), restaging after therapy (53%), routine surveillance (15%), or assessment of extrathoracic disease (1%). Clinically unsuspected PE were detected in 18 patients (4.4%). The prevalence of unsuspected PE was 6.4% among inpatients and 3.4% among outpatients. PE was more prevalent among patients with metastatic disease (7% versus 2%, p = 0.007) and in patients who had received recent chemotherapy (11% versus 3%, p = 0.008). In 7 (39%) of the 18 patients with clinically unsuspected PE, emboli were only identifiable on the CTPA study and not on the routine chest CT study. The diagnosis of PE led to immediate changes in patient management. CONCLUSION: Clinically unsuspected PE is present in up to 4.4% of oncology patients undergoing CT imaging for indications other than PE diagnosis. Modifying standard CT imaging protocols to include a CTPA examination optimizes their detection and leads to changes in patient management.
Asunto(s)
Hallazgos Incidentales , Neoplasias/diagnóstico por imagen , Embolia Pulmonar/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Angiografía , Anticoagulantes/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Prospectivos , Arteria Pulmonar/diagnóstico por imagen , Embolia Pulmonar/tratamiento farmacológico , Embolia Pulmonar/epidemiologíaRESUMEN
PURPOSE: To report a combined procedure that opens the acutely thrombosed superior vena cava (SVC) to rapidly alleviate symptoms in seriously ill patients with SVC syndrome. CASE REPORTS: Four patients aged 54 to 63 years old with underlying malignancies were referred for treatment of SVC syndrome. All received isolated pharmacomechanical thrombolysis (IPMT) with tissue plasminogen activator delivered in a Trellis Peripheral Infusion System that removed obstructive clot in minutes versus the 24 to 48 hours required for traditional catheter-directed thrombolysis. In each case, stents were inserted immediately following IPMT in a combined procedure lasting <1 hour. Patients exhibited near-immediate relief of debilitating symptoms; completion venography demonstrated patent vessels with excellent blood flow. CONCLUSION: Combining IPMT with immediate stenting during the same session is an effective method for managing acute thrombotic SVC syndrome and limiting the exposure time and number of interventions performed on seriously ill patients.
Asunto(s)
Angioplastia de Balón/instrumentación , Fibrinolíticos/administración & dosificación , Neoplasias/complicaciones , Stents , Síndrome de la Vena Cava Superior/terapia , Trombectomía/instrumentación , Terapia Trombolítica , Activador de Tejido Plasminógeno/administración & dosificación , Anticoagulantes/uso terapéutico , Terapia Combinada , Constricción Patológica , Edema/etiología , Edema/terapia , Diseño de Equipo , Femenino , Heparina de Bajo-Peso-Molecular/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Flebografía , Recurrencia , Síndrome de la Vena Cava Superior/diagnóstico por imagen , Síndrome de la Vena Cava Superior/etiología , Síndrome de la Vena Cava Superior/fisiopatología , Terapia Trombolítica/instrumentación , Factores de Tiempo , Resultado del Tratamiento , Grado de Desobstrucción VascularRESUMEN
OBJECTIVE: To assess the feasibility and utility of magnetic resonance (MR) imaging of the bowel in concurrent small- and large-bowel evaluation for the presence of inflammatory bowel disease (IBD). METHODS: Over a 5-year period, 62 MR examinations performed on 53 patients demonstrated evidence of IBD. Sixteen of these 53 (30.1%) patients had imaging findings of colonic disease and underwent 19 formal MR small bowel examinations. These were further evaluated for bowel distention and image quality. The sensitivity and specificity of the technique compared with colonoscopy as the 'gold standard' was evaluated. RESULTS: Simultaneous imaging of the colon is feasible at MR small bowel follow-through with moderate-to-excellent colonic visibility and colon distention obtained when the contrast medium is present in the colon at the time of image acquisition. MR imaging had a sensitivity of 80% (0.56-0.93), specificity of 100% (0.77-1.00), positive predictive value (PPV) of 1 and a negative predictive value (NPV) of 0.8 for the identification of colitis (based on available concurrent correlation of 38/62 examinations with colonoscopy). CONCLUSION: Small and large bowel MR imaging with orally consumed contrast medium represents a promising, feasible, non-invasive, non-radiating single mode of assessment of the entire gastrointestinal tract, performed at a single sitting.
Asunto(s)
Colitis/diagnóstico , Medios de Contraste , Enteritis/diagnóstico , Enfermedades Inflamatorias del Intestino/diagnóstico , Imagen por Resonancia Magnética , Administración Oral , Colonoscopía/métodos , Humanos , Intestino Grueso/diagnóstico por imagen , Intestino Grueso/patología , Intestino Delgado/diagnóstico por imagen , Intestino Delgado/patología , Variaciones Dependientes del Observador , Radiografía , Sensibilidad y EspecificidadRESUMEN
OBJECTIVE: The purpose of our study was to evaluate the potential role of an MR small-bowel follow-through (SBFT) technique in the investigation of suspected pediatric small-bowel abnormalities. MATERIALS AND METHODS: Between September 2003 and January 2008, 280 MR SBFT examinations were performed for investigation of known or suspected small-bowel abnormalities, including 19 of 280 examinations in 17 children (mean age, 13 years; age range 6-17 years), representing the current study population. A standardized technique was used in all cases, including axial and coronal steady-state free precession acquisitions at successive time intervals until completion. Retrospective analysis of the studies obtained was performed by two radiologists, who blindly and independently scored predefined small-bowel segments according to the degree of luminal distention achieved. Any pathologic lesions detected were also noted. Indicators of examination success as a whole (volume, tolerability, and side effects of oral contrast material) were also noted, as were details pertaining to examination duration (number of visits to the MR table, total table time). RESULTS: Oral contrast medium was ingested and subsequent imaging was possible in all patients; 84.2% of patients tolerated the oral contrast material well and 15.8% showed moderate tolerance. The MR table time ranged from 2 to 4 minutes, without early termination of the examination in any case. The average number of visits to the MR table was 1.3 (range, 1-3). The mean duration for complete small-bowel evaluation was 25 minutes (range, 20-60 minutes). The mean distention scores were well within the diagnostic range in all small-bowel segments for both observers, with a substantial degree of interobserver agreement in score assignment (kappa = 0.73). Pathologic lesions were identified in 53% of studies. CONCLUSION: MR SBFT represents a promising, and perhaps optimal, technique for pediatric small-bowel evaluation for a variety of reasons, including its high tolerability, lack of ionizing radiation, avoidance of duodenojejunal intubation, and excellent luminal distention achieved. Furthermore, this technique allows "pseudodynamic" functional imaging while also showing extraluminal disease, without known biologic risk.